Historical shareholding details of iShares Russell 2000 Value ETF holdings in Cg Oncology Inc. (CGON)

Monthly changes of iShares Russell 2000 Value ETF shareholding in Cg Oncology Inc. over the previous months

Month Name Total no. shares held Percent Holding
Mar 31, 2025 Ishares Russell 2000 Value Etf 195,337 0.26%
Mar 28, 2025 Ishares Russell 2000 Value Etf 195,337 0.26%
Mar 25, 2025 Ishares Russell 2000 Value Etf 194,662 0.26%
Feb 28, 2025 Ishares Russell 2000 Value Etf 170,683 0.22%
Feb 26, 2025 Ishares Russell 2000 Value Etf 172,335 0.23%
Jan 31, 2025 Ishares Russell 2000 Value Etf 172,925 0.23%
Jan 29, 2025 Ishares Russell 2000 Value Etf 171,745 0.23%
Jan 28, 2025 Ishares Russell 2000 Value Etf 171,745 0.23%
Dec 31, 2024 Ishares Russell 2000 Value Etf 176,583 0.23%
Dec 30, 2024 Ishares Russell 2000 Value Etf 181,539 0.24%
Dec 27, 2024 Ishares Russell 2000 Value Etf 182,011 0.24%
Nov 30, 2024 Ishares Russell 2000 Value Etf 182,365 0.27%
Nov 27, 2024 Ishares Russell 2000 Value Etf 182,247 0.27%
Oct 31, 2024 Ishares Russell 2000 Value Etf 177,173 0.26%
Oct 30, 2024 Ishares Russell 2000 Value Etf 177,173 0.26%
Oct 29, 2024 Ishares Russell 2000 Value Etf 177,173 0.26%
Sep 30, 2024 Ishares Russell 2000 Value Etf 176,937 0.26%
Sep 27, 2024 Ishares Russell 2000 Value Etf 176,937 0.26%
Sep 25, 2024 Ishares Russell 2000 Value Etf 176,937 0.26%
Aug 30, 2024 Ishares Russell 2000 Value Etf 86,068 0.13%
Aug 29, 2024 Ishares Russell 2000 Value Etf 86,358 0.13%
Aug 28, 2024 Ishares Russell 2000 Value Etf 86,010 0.13%
Jul 31, 2024 Ishares Russell 2000 Value Etf 86,416 0.13%
Jul 29, 2024 Ishares Russell 2000 Value Etf 85,488 0.13%
Jul 26, 2024 Ishares Russell 2000 Value Etf 85,488 0.13%
Jun 28, 2024 Ishares Russell 2000 Value Etf 85,952 0.13%
Jun 13, 2024 Ishares Russell 2000 Value Etf 114,129 0.17%
May 29, 2024 Ishares Russell 2000 Value Etf 116,208 0.17%
Apr 26, 2024 Ishares Russell 2000 Value Etf 119,288 0.18%
Mar 28, 2024 Ishares Russell 2000 Value Etf 121,290 0.18%
Mar 27, 2024 Ishares Russell 2000 Value Etf 118,339 0.18%

View all ownership details of Cg Oncology Inc.